Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

0.00 (0.00%)

< Home < Back

Dr. Reddys Laboratories Ltd. News

>>

Dr. Reddy’s Laboratories informs about disclosure

>>

Dr. Reddy's Laboratories completes Phase 1 study of proposed biosimilar of Tocilizumab

>>

Dr.Reddy's Laboratories informs about press release

>>

Dr. Reddy's Laboratories’ arm enters into agreement to sell certain assets, liabilities

>>

Dr. Reddy’s Laboratories informs about asset purchase agreement of subsidiary company

>>

Dr Reddy's Laboratories informs about press release

>>

Dr. Reddy's Laboratories’ arm reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis

>>

Dr.Reddy's Laboratories informs about analyst meet

>>

Dr. Reddy's arm recalls over 48,000 cartons of drug used to treat sneezing, runny or stuffy nose

>>

Dr Reddy's Laboratories earmarks capex of around Rs 1,500 crore for FY23

<< < 26 27 28 ...143 > >>